01Controlled medicine identity, storage, distribution and finance

Pharmacy & Pharmaceutical Software in Afghanistan

Connect medicine catalogues, suppliers, purchasing, receipt, quarantine, batch and expiry stock, storage conditions, wholesale or retail sales, returns, recalls and finance.

INDIndustry operating model

Connect operations, control and decisions.

Operations
Catalogue, purchasing, receipt, storage, distribution, sale, return and recall.
Control
Product identity, supplier approval, quality status, batch, expiry, conditions and authorization.
Decisions
Availability, short expiry, quarantine, recall exposure, stock loss, credit and margin.
Medicine cataloguePurchasing & receiptBatch & expiryStorage controlWholesale & retailReturns & recallsCredit & financeDarmal ERP

Pharmaceutical software should preserve product quality and accountability through the supply chain

A pharmacy or pharmaceutical platform connects the approved medicine identity with supplier qualification, purchasing, receipt, quarantine, release, storage, batch and expiry, distribution, sale, return, recall and financial records. It should explain who handled each movement and under which approved status.

Authorized pharmaceutical, quality, clinical, regulatory, finance and management professionals must approve product, prescription, storage, pricing, release, recall and disposal rules. Software can apply and evidence those decisions; it does not establish that a medicine, supplier, prescription or transaction is lawful or clinically appropriate.

Medicine catalogue and governed master data

  • Approved generic and brand identity where applicable
  • Strength, dosage form, pack, unit and controlled conversions
  • Manufacturer, supplier and authorized product references
  • Batch, expiry, barcode and storage requirements
  • Purchase, wholesale, retail and other approved price structures
  • Prescription, restriction or classification flags defined by authorized owners

Master data should distinguish verified regulatory information from commercial descriptions. Changes to units, pack sizes, restrictions and identifiers require controlled review because they can affect purchasing, dispensing, stock and reporting.

Supplier qualification, purchasing and receipt

Procurement can connect approved suppliers, quotations, purchase orders, delivery documents, invoices and payment terms. Receipt records may include supplier, product, batch, quantity, expiry, condition, transport evidence and receiving user. Technical or quality acceptance should remain separate from financial receipt where policy requires it.

Quarantine, release and stock status

Stock may need distinct available, quarantine, rejected, returned, recalled, damaged or expired states. The system should prevent restricted stock from being sold or issued under the approved rules. Only authorized roles can release, reclassify or dispose of stock, with reason and evidence retained.

Batch, expiry, storage and stock rotation

Every applicable movement should preserve product, batch, expiry, location, quantity, unit and source document. FEFO or another approved rotation policy can guide allocation, but staff must review exceptions. Storage locations may require temperature, humidity, security, segregation or other conditions defined by the responsible professionals.

Temperature excursions and cold-chain evidence

Where temperature-sensitive products are handled, the platform may connect devices or logs, shipment and storage periods, excursion alerts, investigation and disposition. A temperature alert does not itself decide product usability. Qualified owners review duration, limits, product evidence and current requirements.

Wholesale, retail and prescription workflows

Wholesale workflows may connect licensed customers, orders, allocation, picking, packing, dispatch, invoices, credit and statements. Retail pharmacy workflows may include authorized patient or customer records, prescriptions, dispensing, substitutions, payments and returns according to approved professional and regulatory requirements.

The system must not infer prescribing authority, medicine eligibility or substitution rules. These require current institutional policy and qualified approval.

Returns, recalls, complaints and disposal

Returns should retain original sale or distribution, product, batch, quantity, condition, reason and disposition. Recall workflows can identify affected stock and recipients, block further movement, record communication, reconcile recovered quantities and preserve closure evidence. Complaints, suspected quality problems and falsified products need controlled escalation.

Finance, credit and profitability

Purchases, sales, returns, discounts, taxes where applicable, cash, credit, receivables and payables can connect to accounting. Cost, margin and expiry-loss reports depend on approved valuation and allocation rules. Financial posting does not replace pharmaceutical release or disposal authorization.

Security, continuity and auditability

Access should separate catalogue administration, purchasing, receipt, quality release, warehouse handling, dispensing or sale, pricing, finance and system administration. Offline or downtime procedures must preserve batch, quantity, documents and later reconciliation. Backups, recovery tests, protected credentials and activity records are operational requirements.

Implementation, migration and UAT

Implementation maps business type, licences or authorizations, products, packs, suppliers, locations, quality statuses, pricing, roles, reports and integrations. Migration should validate product identity, unit conversion, batch, expiry, stock status, balances and open transactions. UAT should cover receipt exceptions, quarantine, release, short expiry, returns, recalls, credit, corrections and downtime.

Storage and distribution reference

The operating model was cross-checked against the World Health Organization’s Good Storage and Distribution Practices for medical products, including quality systems, complaints, returns, recalls, stock control, storage, documentation and authorized operations. This is a planning reference, not WHO endorsement or proof of regulatory compliance.

02Direct answers

Frequently asked questions.

Clear, practical answers about the service, implementation and fit.

01Is the industry page the same as Darmal ERP?

No. This page explains the operating model for pharmacy and pharmaceutical organizations. Darmal is Fida’s separate product profile, and its available scope must be confirmed before commitment.

02Can the system block expired or quarantined stock?

Approved status and expiry rules can prevent sale or issue, while authorized pharmaceutical or quality roles control release, exceptions and disposition.

03Can medicine recalls be traced by batch?

Where batch data is consistently captured, a recall workflow can identify affected stock and recipients, block movement, track communication and reconcile recovered quantities.

04Can temperature-monitoring devices be integrated?

Integration can be evaluated after devices, limits, timestamps, locations, connectivity, alerts, evidence retention and qualified excursion-review responsibilities are defined.

05What pharmaceutical data should be migrated?

Approved products, units, suppliers, locations, quality statuses, batches, expiry dates, opening stock, balances and open transactions can be migrated after validation.

06How is pharmaceutical software priced?

Pricing depends on business type, sites, products, users, batch and storage controls, wholesale or retail workflows, devices, integrations, migration, validation and support.